Treatment Interruption of Natalizumab

Clinical trial NCT01071083 · COMPLETED

Trial details

NCT number: NCT01071083
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2010-03-01
Primary completion: 2011-11-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.